Fladrafinil was 1st formulated by the French pharmaceutical firm Lafon Laboratories in the 1970s as component in their analysis into wakefulness-promoting agents. Fladrafinil metabolizes into modafinil in the human body while simultaneously inhibiting dopamine reuptake and influencing histamine and norepinephrine pathways. Fladrafinil involves lessen dosages than both modafinil and ad... https://milesv357sxa3.wikievia.com/user